---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-424228"
form_type: "8-K"
ticker: "HURA"
cik: "0001498382"
company_name: "TuHURA Biosciences, Inc./NV"
filed_at: "2026-10-16T21:00:14+00:00"
generated_at: "2026-10-16T21:02:12.082661+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# TuHURA Biosciences draws $650K under $50M Parkview revolving credit facility

## Summary
- On October 9, 2026 the Company borrowed an additional $650,000 under the revolving credit facility; proceeds to be used for general corporate purposes.
- Facility is with Parkview Holdings One LLC under a Loan Agreement dated April 21, 2026, matures April 21, 2031, maximum availability $50 million.
- Company notes the lender is an affiliate of its largest stockholder and cites potential conflicts of interest as a risk factor.
- Filing warns funds available under the Loan Agreement may be insufficient to fund operations and development programs as anticipated.

## SEC filing metadata
- accession: 0001193125-26-424228
- form_type: 8-K
- ticker: HURA
- cik: 0001498382
- company_name: TuHURA Biosciences, Inc./NV
- filed_at: 2026-10-16T21:00:14+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1498382/000119312526424228/0001193125-26-424228-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1498382/000119312526424228/hura-20261009.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-424228
- JSON: https://secwatch.observer/filing/0001193125-26-424228.json
- Plain text: https://secwatch.observer/filing/0001193125-26-424228.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.